PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
+6.33%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.44B
AUM Growth
+$2.44B
(+14%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
9.57%
Top 10 Holdings %
Top 10 Hldgs %
25.16%
Holding
1,474
New
164
Increased
1,047
Reduced
225
Closed
36
Top Buys
| 1 |
Gilead Sciences
GILD
|
$10.8M |
| 2 |
Amgen
AMGN
|
$9.46M |
| 3 |
AbbVie
ABBV
|
$8.14M |
| 4 |
CELG
Celgene Corp
CELG
|
$6.77M |
| 5 |
Biogen
BIIB
|
$6.24M |
Top Sells
| 1 |
CHL
China Mobile Limited
CHL
|
$2.81M |
| 2 |
TSMC
TSM
|
$2.38M |
| 3 |
LFC
China Life Insurance Company Ltd.
LFC
|
$2.04M |
| 4 |
Freeport-McMoran
FCX
|
$1.99M |
| 5 |
Baidu
BIDU
|
$1.96M |
Sector Composition
| 1 | Healthcare | 32.89% |
| 2 | Technology | 14.27% |
| 3 | Financials | 7.49% |
| 4 | Consumer Discretionary | 6.73% |
| 5 | Communication Services | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $111M | 4.55% | 1,178,471 +114,398 | +11% | +$10.8M |
|
|
2
Amgen
AMGN
$155B
| $94.6M | 3.87% | 593,748 +59,402 | +11% | +$9.46M |
|
|
3
AbbVie
ABBV
$372B
| $75.9M | 3.11% | 1,159,158 +124,364 | +12% | +$8.14M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $69.8M | 2.86% | 623,559 +60,530 | +11% | +$6.77M |
|
|
5
Biogen
BIIB
$19.4B
| $62.7M | 2.57% | 184,647 +18,394 | +11% | +$6.24M |
|
6
Apple
AAPL
$3.45T
| $57.9M | 2.37% | 524,832 -6,284 | -1% | -$694K |
|
7
Intel
INTC
$107B
| $41.1M | 1.68% | 1,133,814 +34,176 | +3% | +$1.24M |
|
8
Microsoft
MSFT
$3.77T
| $34.6M | 1.42% | 744,208 +7,561 | +1% | +$351K |
|
9
Johnson & Johnson
JNJ
$427B
| $33.7M | 1.38% | 321,883 +34,806 | +12% | +$3.64M |
|
10
Alphabet (Google) Class C
GOOG
$2.58T
| $33.4M | 1.37% | 63,150 -1,112 | -2% | -$588K |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $28.7M | 1.17% | 155,094 +15,662 | +11% | +$2.9M |
|
12
Exxon Mobil
XOM
$487B
| $27.3M | 1.12% | 295,127 +9,734 | +3% | +$900K |
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $24.1M | 0.99% | 58,855 +5,538 | +10% | +$2.27M |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $22.2M | 0.91% | 186,833 +18,707 | +11% | +$2.22M |
|
15
Pfizer
PFE
$141B
| $22.1M | 0.91% | 710,119 +71,188 | +11% | +$2.22M |
|
16
Illumina
ILMN
$15.8B
| $19.9M | 0.82% | 107,958 +12,359 | +13% | +$2.28M |
|
17
Meta Platforms (Facebook)
META
$1.86T
| $19.6M | 0.8% | 250,887 -3,235 | -1% | -$252K |
|
18
Merck
MRK
$210B
| $18.6M | 0.76% | 327,873 +34,007 | +12% | +$1.93M |
|
19
Amazon
AMZN
$2.44T
| $17.3M | 0.71% | 55,621 -1,319 | -2% | -$409K |
|
20
Chevron
CVX
$324B
| $15.3M | 0.62% | 135,959 +5,849 | +4% | +$656K |
|
21
Comcast
CMCSA
$125B
| $14.1M | 0.58% | 242,499 +22,906 | +10% | +$1.33M |
|
22
Texas Instruments
TXN
$184B
| $13.1M | 0.54% | 244,969 +9,047 | +4% | +$484K |
|
23
Cisco
CSCO
$274B
| $12.8M | 0.53% | 461,830 +5,098 | +1% | +$142K |
|
24
Wells Fargo
WFC
$263B
| $12.5M | 0.51% | 227,304 -5,586 | -2% | -$306K |
|
25
Procter & Gamble
PG
$368B
| $11.9M | 0.49% | 130,365 +35,015 | +37% | +$3.19M |
|